MedPath

Dorzolamide Hydrochloride/Timolol Maleate/Brimonidine Tartrate

Generic Name
Dorzolamide Hydrochloride/Timolol Maleate/Brimonidine Tartrate

A Randomized, Open-label, Active-controlled, Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of TFC-003 in Patients With Primary Open-angle Glaucoma or Ocular Hypertension

Phase 2
Not yet recruiting
Conditions
Primary Open Angle Glaucoma
Ocular Hypertension
Interventions
First Posted Date
2023-12-20
Last Posted Date
2023-12-20
Lead Sponsor
Kukje Pharma
Target Recruit Count
60
Registration Number
NCT06177678
Locations
🇰🇷

Kukje Pharm, Seongnam-si, Korea, Republic of

Safety and Tolerability of the Preservative-free Ophthalmic Solution PRO-122 Compared With Krytantek Ofteno®

Phase 1
Completed
Conditions
Glaucoma
Interventions
Drug: Krytantek Ofteno®
First Posted Date
2019-05-29
Last Posted Date
2019-12-13
Lead Sponsor
Laboratorios Sophia S.A de C.V.
Target Recruit Count
24
Registration Number
NCT03966365
Locations
🇲🇽

Unidad Clínica de Bioequivalencia, S. de R.L. de C.V., Guadalajara, Jalisco, Mexico

Non-inferiority of PRO-122 Ophthalmic Solution vs KRYTANTEK Ofteno® in Glaucoma or Ocular Hypertension (CONFORTK)

Phase 3
Completed
Conditions
Primary Open Angle Glaucoma
Ocular Hypertension
Interventions
Drug: Krytantek Ofteno®
First Posted Date
2017-08-22
Last Posted Date
2019-12-09
Lead Sponsor
Laboratorios Sophia S.A de C.V.
Target Recruit Count
60
Registration Number
NCT03257813

PRO-122 Versus Concomitant Therapy in Subjects With Uncontrolled Primary Open-angle Glaucoma (PRO-122LATAM)

Phase 3
Terminated
Conditions
Primary Open-angle Glaucoma
Interventions
Other: Placebo1
Drug: Dorzolamide-Timolol Ophthalmic
Other: Placebo 2
Drug: Krytantek
First Posted Date
2017-06-20
Last Posted Date
2025-03-06
Lead Sponsor
Laboratorios Sophia S.A de C.V.
Target Recruit Count
51
Registration Number
NCT03193333
Locations
🇨🇴

MD. Sandra Belalcazar Rey, Bogotá, Bogotá D.C., Colombia

🇲🇽

MD. Victoria Eugenia Sanchez Castellanos, Zapopan, Jalisco, Mexico

© Copyright 2025. All Rights Reserved by MedPath